The European Medicines Agency remains firmly convinced of the benefits of AstraZeneca’s vaccine, despite several countries suspending its rollout over blood clotting concerns. Epidemiologist and professor in medicine at the University of East Anglia Paul Hunter weighs in.
#AstraZeneca
Subscribe: [ Ссылка ]
Livestream: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Visit our website: [ Ссылка ]
